AMs have been shown to promote a pro-tumorigenic NSCLC microenvironment via direct the secretion of anti-inflammatory IL10 or the enhancement of TGFβ secretion by tumor cells [106,107]. The gene discussed is IL10; the disease is non-small cell lung carcinoma.